These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2256478

  • 21. Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.
    Joven J, Vilella E, Camps J, Masana L, Turner PR, Simó JM, Villabona C.
    Nephron; 1990; 56(4):399-404. PubMed ID: 2079999
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
    Marsh JB, Sparks CE.
    J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.
    Joven J, Espinel E, Simó JM, Vilella E, Camps J, Oliver A.
    Atherosclerosis; 1996 Oct 25; 126(2):243-52. PubMed ID: 8902150
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD, Stroes ES, Willekes-Koolschijn N, Rabelink TJ, Koomans HA, Joles JA.
    Kidney Int; 1999 Mar 25; 55(3):1005-10. PubMed ID: 10027937
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.
    McKenzie IF, Nestel PJ.
    J Clin Invest; 1968 Jul 25; 47(7):1685-95. PubMed ID: 5658595
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M.
    N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443
    [Abstract] [Full Text] [Related]

  • 38. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN, Tvorogova MG, Levitova EN, Krylova EA.
    Vopr Med Khim; 1983 Aug 30; 29(2):17-23. PubMed ID: 6858031
    [Abstract] [Full Text] [Related]

  • 39. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG, Kashyap ML, Chen CY, Lutmer RF.
    Metabolism; 1976 Oct 30; 25(10):1143-9. PubMed ID: 184367
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.